BioCatalystWatch
JANXWorkspace / JANX / OverviewCompany library
Janux Therapeutics, Inc. logo

Janux Therapeutics, Inc.

Janux Therapeutics, Inc. (JANX)

Website

Price
Market cap
Next catalystExpected 1H 2027JANX011 · Trial initiationCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

JANX007

PSMA × CD3

PreINDP1P2P3FilingApproved
Upcoming / outlook

JANX011

CD19

PreINDP1P2P3FilingApproved

JANX007

CD3 / PSMA

Upcoming / outlook

JANX011

CD19

Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

JANX007

PSMA × CD3

PreINDP1P2P3FilingApproved
Upcoming / outlook

JANX011

CD19

Upcoming / outlook

JANX007

CD3 / PSMA

Upcoming / outlook

JANX011

CD19

PreINDP1P2P3FilingApproved

Other pipelines

PSMA × CD28

PreINDP1P2P3FilingApproved
JANX014

PSMA × CD3

PreINDP1P2P3FilingApproved
TROP2-TRACTr

TROP2

PreINDP1P2P3FilingApproved

History / paused

CD3 / EGFR

PreINDP1P2P3FilingApproved

CD3 / EGFR

PreINDP1P2P3FilingApproved

CD3 / EGFR

PreINDP1P2P3FilingApproved

CD3 / EGFR

PreINDP1P2P3FilingApproved

PD-L1 × CD28

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

JANX PR & News

PR & News

JANX SEC archive